← Open Payments lookup

ROSETTA GOODSON-REDMOND: Open Payments

NPI 1508222993 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$741 in 26 payments from 12 companies in 2025. Trend: 2023 $24 · 2024 $95 · 2025 $741

Food & beverage: $656Education: $85
CompanyPaymentsAmount
Janssen Biotech, Inc.6$233
Gilead Sciences, Inc.3$127
ABBVIE INC.4$83
Merck Sharp & Dohme LLC3$68
Daiichi Sankyo Inc.2$51
Karyopharm Therapeutics Inc.2$41
AstraZeneca Pharmaceuticals LP1$31
Regeneron Healthcare Solutions, Inc.1$29
Genentech USA, Inc.1$26
PFIZER INC.1$22

Products named: ERLEADA, Trodelvy, VENCLEXTA, RYBREVANT, KEYTRUDA, XPOVIO, LIBTAYO, Enhertu.

Industry payments across GA — which companies pay providers there.